• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CARL ZEISS MEDITEC CATARACT TECHNOLOGY INC. MICOR LENS FRAGMENTATION SYSTEM; PHACOFRAGMENTATION SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CARL ZEISS MEDITEC CATARACT TECHNOLOGY INC. MICOR LENS FRAGMENTATION SYSTEM; PHACOFRAGMENTATION SYSTEM Back to Search Results
Model Number FG-50621
Device Problem Use of Device Problem (1670)
Patient Problem Capsular Bag Tear (2639)
Event Date 07/12/2023
Event Type  Injury  
Manufacturer Narrative
The micor extractor was returned to the manufacturer and evaluated.The device was subjected to visual inspection and functional testing.There was no damage or device malfunction identified and the device met specifications and performed as intended.The published literature was reviewed for comparison of the functional test results for occlusion response; the investigation data shows the device operates within the same expected ranges for similar marketed phacoemulsification devices.The surgical video was provided to the manufacturer for review and the following summary represents the medical review by the company medical affairs director / ophthalmologist.Cataract extraction was completed.As the spatula was removed from the secondary incision aqueous fluid leaked out of the incision and resulted in an unstable anterior chamber.Within 10 seconds, a posterior capsular tear occurred near the 10 - 12 o'clock position.At the time of the tear the micor extractor was positioned near the center cortex and the throttle was still engaged.There was no evidence of anterior chamber collapse and no vitreous fluid loss.The unstable anterior chamber made the capsular bag more susceptible to damage.As with any cataract surgery, caution should be exercised to control aspiration speed when there is evidence of chamber instability.These findings are consistent with the surgeon's assessment that "chamber instability" caused or contributed to the posterior capsule tear.The micor extractor device history records were reviewed for this manufacturing lot and there were no discrepancies or unusual findings that relate to the reported event.Based on the information reviewed, there is no evidence to indicate the presence of a potential quality issue with respect to manufacturing, design, or labeling.The device labeling identifies capsular rupture as an inherent safety risk.Manufacturer's reference #: (b)(4).
 
Event Description
A patient underwent cataract surgery in the right eye on (b)(6) 2023 where the micor lens fragmentation system (extractor and drive) was used to remove the cataractous lens fragments.Immediately following lens extraction with the micor extractor there was anterior chamber fluctuation (ac shallowing) and the posterior capsule tore.There was no vitreous loss and the planned intraocular lens was implanted.Preoperatively, the patient's best corrected visual acuity (bcva) in the operative eye was 20/50, improving to 20/30 one week postoperatively.At this one-week postoperative visit the patient was reported as stable and improving with 1+ corneal edema that was resolving.
 
Manufacturer Narrative
The surgical video was sent to an ophthalmologist for a second medical opinion.After review of the video, the physician concluded that the posterior capsule may have been compromised earlier than first thought (~minute 3:29-3:32) due to motion of the lens fragments contacting the capsule.The tip of the micor extractor cannula was in the correct position.The findings and conclusions codes remain unchanged.Manufacturer's reference #: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MICOR LENS FRAGMENTATION SYSTEM
Type of Device
PHACOFRAGMENTATION SYSTEM
Manufacturer (Section D)
CARL ZEISS MEDITEC CATARACT TECHNOLOGY INC.
8740 technology way
reno NV 89521
Manufacturer (Section G)
CARL ZEISS MEDITEC CATARACT TECHNOLOGY, INC.
8740 technology way
reno NV 89521
Manufacturer Contact
andrew rybold
8740 technology way
reno 89521
7754731014
MDR Report Key17505268
MDR Text Key320854046
Report Number3012123033-2023-00004
Device Sequence Number1
Product Code HQC
UDI-Device Identifier00860000122368
UDI-Public00860000122368
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K222236
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 09/22/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/05/2023
Device Model NumberFG-50621
Device Lot NumberFG23060701
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/25/2023
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received08/10/2023
Supplement Dates Manufacturer Received07/12/2023
Supplement Dates FDA Received09/22/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured06/08/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
SPATULA
Patient Outcome(s) Required Intervention;
Patient Age72 YR
Patient SexMale
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-